Investigators at the UCLA Health Jonsson Comprehensive Cancer Center have received an $800,000 grant from the V Foundation to find new ways to treat and prevent a severe...
TOPLINE: Surveillance of high-risk individuals may detect pancreatic ductal adenocarcinoma at an earlier stage, when the tumor is smaller and easier to treat, and could help...
Investigators at the UCLA Health Jonsson Comprehensive Cancer Center have uncovered new details about the role of a protein called interferon regulatory factor (IRF1) in cancer progression and treatment response,...
There’s a frustrating fact about today’s immunotherapies for cancer. While sometimes they work beautifully -; completely eliminating or greatly reducing cancer in particular patients -; other times...
In a recent study published in Cell, a group of researchers elucidated the shared immune tolerance mechanisms in cancer and pregnancy, focusing on the role of...
In a recent study published in the journal Gut Pathogens, researchers from China reviewed the metabolism of soy isoflavones (SI) into a metabolite named “equol” by...
Twelve years ago, cancer researchers at University of California San Diego identified a molecule that helps cancer cells survive by shuttling damaging inflammatory cells into tumor...
A new Finnish study from University of Turku shows that already a 30-minute exercise can increase the proportion of tumor-killing white blood cells in the bloodstream...
A recent Nutrients journal study assesses the possible interplay between inflammation, carbohydrate intake, and the development of atherosclerotic cardiovascular disease (ASCVD) development. Study: The Impact of Dietary...
Tumors arising in the base of the skull are among the most difficult to remove in neurosurgery. The current treatment method is to perform surgical removal...
Multiple myeloma is one of the most common forms of cancer of the immune cells in the bone marrow. It is considered incurable. Even when patients...
Announcing a new publication for Acta Materia Medica journal. Elevated cellular oxidative stress is a common marker of cancer cell dysregulation caused by malignant transformation. Thioredoxin...